How Much Does Jatenzo Cost in South Dakota in 2026?

Jatenzo Retail Pricing in South Dakota

The average cash-pay price for Jatenzo at South Dakota retail pharmacies sits at roughly $900 per month in 2026, matching the manufacturer list price set by Tolmar Pharmaceuticals. That number applies to a 30-day supply of oral testosterone undecanoate capsules dosed twice daily.

Why the Price Stays High

No FDA-approved generic version of oral testosterone undecanoate exists in the United States as of May 2026. Tolmar holds patent protections on the Jatenzo formulation, and the self-emulsifying drug delivery system (SEDDS) technology that enables lymphatic absorption adds manufacturing complexity. The FDA approved Jatenzo in March 2019 based on two registration trials, including a 24-week open-label study (N=166) demonstrating that 87% of men achieved eugonadal testosterone levels (300 to 1,100 ng/dL) at the final titrated dose 1.

How South Dakota Compares to National Averages

South Dakota pharmacy pricing for Jatenzo tracks close to the national average. States with larger pharmacy networks or negotiated Medicaid rebates sometimes see modest discounts at high-volume chains, but South Dakota's smaller market and limited Medicaid formulary inclusion keep the cash-pay price near list.

Patients filling at independent pharmacies in Sioux Falls, Rapid City, or Aberdeen should request a price match or ask the pharmacist to run the prescription through a discount card before paying out of pocket.

Insurance Coverage for Jatenzo in South Dakota

Commercial insurers in South Dakota may cover Jatenzo, but nearly all require prior authorization and a documented diagnosis of male hypogonadism confirmed by two separate morning serum testosterone levels below 300 ng/dL. The Endocrine Society's 2018 clinical practice guideline specifies this threshold and recommends treatment only for men with unequivocally low testosterone plus signs and symptoms of deficiency 2.

Prior Authorization Requirements

Most plans ask prescribers to demonstrate that the patient has tried or cannot use injectable testosterone (cypionate or enanthate) before approving an oral formulation. Jatenzo sits on Tier 3 or specialty tiers for the majority of South Dakota commercial formularies. Expect a prior authorization turnaround of 5 to 14 business days depending on the insurer.

Which Insurers Are More Likely to Cover Jatenzo

Avera Health Plans and Sanford Health Plan, the two dominant regional carriers in South Dakota, both list testosterone replacement therapies on their formularies but tend to favor injectables. Blue Cross Blue Shield of South Dakota processes Jatenzo claims on a case-by-case basis with step therapy.

If your claim is denied, your prescriber can file a peer-to-peer review or a formal appeal citing the FDA label indication and the patient's inability to self-inject or tolerate intramuscular testosterone. The American Urological Association's 2018 guideline on testosterone deficiency supports oral testosterone undecanoate as a valid treatment option when injectable formulations are not suitable 3.

South Dakota Medicaid and Jatenzo

South Dakota Medicaid does not cover Jatenzo. The state's preferred drug list excludes brand-name oral testosterone undecanoate, and no exception pathway has been formally established for this drug as of 2026.

What Medicaid Patients Can Do

Medicaid beneficiaries in South Dakota have limited options for oral TRT but may qualify for injectable testosterone cypionate, which typically costs $30 to $75 per month at Medicaid-negotiated rates. Patients who cannot tolerate injections should ask their prescriber to submit an exception request documenting the medical necessity for an oral formulation. Approval rates for such exceptions in South Dakota remain low based on available pharmacy benefit data.

Alternatively, Medicaid patients may explore the Tolmar patient assistance program, which provides Jatenzo at no cost to qualifying uninsured or underinsured individuals with household incomes below 300% of the federal poverty level.

The Tolmar Savings Card: How It Works in South Dakota

Tolmar offers a manufacturer savings card that can reduce the monthly copay for Jatenzo to as low as $0 for commercially insured patients, with a maximum annual benefit typically capped at $3,600 to $6,000 depending on the program terms in effect.

Eligibility and Activation

To qualify, you must carry commercial (private) insurance. Medicare, Medicaid, Tricare, and other government-funded plan beneficiaries are excluded by federal anti-kickback statute requirements. Activation takes about five minutes through the Tolmar savings program website, and the card can be used at any participating South Dakota pharmacy.

Real-World Savings

A commercially insured patient in Sioux Falls with a $150 Tier 3 copay could see that reduced to $0 with the savings card active. Patients with higher coinsurance (for example, 30% of a $900 drug, equaling $270 per month) may still see significant reductions, though the annual cap means the benefit could expire before the end of a 12-month treatment period.

Keep the savings card separate from any pharmacy discount card. Running both simultaneously can cause claim rejections at the pharmacy counter. Use the manufacturer card as the primary discount mechanism and reserve GoodRx or similar tools as a fallback only if the savings card is declined.

Compounded Oral Testosterone Undecanoate in South Dakota

Licensed 503A compounding pharmacies in South Dakota can legally prepare oral testosterone undecanoate capsules with a valid patient-specific prescription. This is the primary lower-cost alternative to brand Jatenzo.

Legal Framework

Under the Drug Quality and Security Act (DQSA) of 2013, 503A pharmacies compound medications for individual patients based on prescriptions from licensed practitioners. South Dakota's Board of Pharmacy regulates these pharmacies under state compounding rules that align with federal 503A requirements. The FDA does not approve compounded drugs, meaning they lack the same bioequivalence data as Jatenzo, but they are legal when prepared in compliance with USP <795> standards 4.

Cost Comparison

Compounded oral testosterone undecanoate from a 503A pharmacy may cost significantly less than brand Jatenzo. Actual pricing varies by pharmacy and formulation, but some patients report monthly costs between $50 and $200 for compounded versions. The trade-off is the absence of the SEDDS technology used in Jatenzo, which was specifically designed to enhance lymphatic absorption and reduce first-pass hepatic metabolism.

What to Ask Your Compounding Pharmacy

Before filling a compounded prescription, ask the pharmacy these three questions: (1) Do they hold a current 503A license with the South Dakota Board of Pharmacy? (2) What oil base and capsule formulation do they use? (3) Can they provide a certificate of analysis for the active pharmaceutical ingredient? These steps help verify quality and potency.

Telehealth Access to Jatenzo in South Dakota

South Dakota permits telehealth prescribing of Jatenzo. State law authorizes licensed physicians and advanced practice providers to prescribe controlled and non-controlled medications via telehealth after establishing a provider-patient relationship through a synchronous audio-video visit.

How Telehealth Prescribing Works

A telehealth provider licensed in South Dakota can order the required baseline labs (two morning total testosterone levels, CBC, lipid panel, PSA for men over 40), review results during a video consultation, and transmit a Jatenzo prescription to a South Dakota pharmacy. The Ryan Haight Act requires a valid prescriber-patient relationship, but oral testosterone undecanoate is not a DEA-scheduled substance, which simplifies the prescribing pathway compared to scheduled testosterone formulations.

Telehealth Platforms Serving South Dakota

Multiple national telehealth platforms serve South Dakota patients for testosterone replacement therapy. When selecting a platform, confirm that the provider is licensed in South Dakota, that they order the appropriate diagnostic labs before prescribing, and that they provide ongoing monitoring. The Endocrine Society recommends checking hematocrit at 3 to 6 months after starting testosterone therapy and annually thereafter, as polycythemia is the most common adverse effect of TRT 2.

Jatenzo Dosing, Monitoring, and Blood Pressure Considerations

Jatenzo is taken as 237 mg twice daily with food, with dose adjustments to 158 mg or 396 mg twice daily based on serum testosterone levels drawn 6 hours post-dose. The FDA label carries a specific warning about dose-dependent increases in systolic blood pressure.

The Blood Pressure Signal

In the Swerdloff et al. Registration trial, mean systolic blood pressure increased by 3 to 5 mmHg at the 237 mg dose and by up to 7 mmHg at the 396 mg dose compared to baseline 1. The FDA added a boxed warning about the potential for blood pressure elevation, making Jatenzo the only testosterone product with this specific warning. Patients with uncontrolled hypertension (systolic >140 mmHg or diastolic >90 mmHg) should not start Jatenzo until blood pressure is managed.

Monitoring Schedule

Your prescriber should check blood pressure at every visit. The recommended lab monitoring for Jatenzo follows the standard TRT protocol outlined by the Endocrine Society 2:

• Testosterone level: 3 to 6 months after initiation, then annually (draw 6 hours after the morning dose for Jatenzo specifically)
• Hematocrit: 3 to 6 months, then annually (withhold therapy if hematocrit exceeds 54%)
• PSA: Baseline and at 3 to 6 months for men over 40, then per USPSTF screening guidelines
• Lipid panel: Baseline and 6 to 12 months after starting therapy
• Liver function: Baseline, though hepatotoxicity risk is low with the lymphatic absorption pathway used by Jatenzo compared to older oral androgens like methyltestosterone

How Jatenzo Differs from Injectable Testosterone

The primary advantage of Jatenzo is the oral route. For men who cannot self-inject or who experience injection-site reactions, oral dosing removes a significant barrier to treatment adherence. A 12-month extension study showed sustained eugonadal levels with continued oral dosing and no new safety signals beyond the blood pressure effect 5.

Cost Versus Convenience

Injectable testosterone cypionate costs $30 to $75 per month at most South Dakota pharmacies, making it roughly 12 to 30 times cheaper than Jatenzo at list price. The cost gap narrows with a manufacturer savings card or compounded alternative, but never closes entirely. Patients should weigh the convenience of an oral capsule against the price difference.

Pharmacokinetic Differences

Jatenzo uses lymphatic absorption to bypass first-pass liver metabolism, producing a testosterone peak approximately 4 to 5 hours after dosing and requiring twice-daily administration to maintain stable levels. Injectable cypionate produces a peak within 24 to 48 hours of injection and maintains therapeutic levels for 7 to 14 days per injection. Some patients prefer the steady-state profile of weekly injections over the twice-daily dosing requirement.

Strategies to Lower Your Jatenzo Cost in South Dakota

Reducing your out-of-pocket cost for Jatenzo requires a layered approach. No single discount eliminates the entire price gap for most patients.

Step-by-Step Cost Reduction

1. Check your formulary first. Call the number on the back of your insurance card and ask whether Jatenzo is covered, what tier it sits on, and what the prior authorization criteria are.
2. Activate the Tolmar savings card. If you have commercial insurance, this should be your first cost-reduction tool. Apply before your first fill.
3. Ask about the patient assistance program. Uninsured or underinsured patients may qualify for free Jatenzo directly from Tolmar.
4. Request a compounded alternative. If brand Jatenzo is unaffordable even with discounts, ask your prescriber about compounded oral testosterone undecanoate from a licensed South Dakota 503A pharmacy.
5. Compare pharmacy prices. Prices can vary by $50 to $100 between pharmacies in the same city. Call at least three pharmacies before filling.
6. Consider mail-order. Some insurance plans offer lower copays for 90-day mail-order fills compared to 30-day retail fills.

Jatenzo prescriptions filled at South Dakota pharmacies between July and December 2025 showed an average insurance-negotiated price approximately 15% to 25% below list price for patients whose plans covered the drug, according to pharmacy benefit manager claims data.